Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-06-12 6:57 pm Sale | 13G | Satsuma Pharmaceuticals Inc. STSA | BML Investment Partners L.P. | 0 0.000% | -6,590,000 (Position Closed) | View |
| 2023-06-12 5:00 pm Sale | 13D | Satsuma Pharmaceuticals Inc. STSA | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -5,944,252 (Position Closed) | View |
| 2023-06-08 09:17 am Sale | 13D | Satsuma Pharmaceuticals Inc. STSA | Shin Nippon Biomedical Laboratories Ltd. | 1,000 100.000% | -2,793,113 (-99.96%) | View |
| 2023-05-02 5:26 pm Sale | 13D | Satsuma Pharmaceuticals Inc. STSA | Growth Equity Opportunities 17 LLC | 0 0.000% | -2,488,587 (Position Closed) | View |
| 2023-04-18 4:30 pm Purchase | 13D | Satsuma Pharmaceuticals Inc. STSA | RA CAPITAL MANAGEMENT L.P. | 5,944,252 17.900% | 30,000 (+0.51%) | View |
| 2023-04-17 4:09 pm Unchanged | 13D | Satsuma Pharmaceuticals Inc. STSA | Shin Nippon Biomedical Laboratories Ltd. | 2,794,113 8.400% | 0 (Unchanged) | View |
| 2023-02-14 1:43 pm Sale | 13G | Satsuma Pharmaceuticals Inc. STSA | SAMLYN CAPITAL LLC | 0 0.000% | -2,570,292 (Position Closed) | View |
| 2023-02-10 4:17 pm Sale | 13G | Satsuma Pharmaceuticals Inc. STSA | TPG GP A LLC | 0 0.000% | -1,885,939 (Position Closed) | View |
| 2023-02-08 4:55 pm Purchase | 13G | Satsuma Pharmaceuticals Inc. STSA | BML Investment Partners L.P. | 6,590,000 19.900% | 150,000 (+2.33%) | View |
| 2023-01-27 4:58 pm Sale | 13D | Satsuma Pharmaceuticals Inc. STSA | Growth Equity Opportunities 17 LLC | 2,488,587 7.500% | -504,371 (-16.85%) | View |
| 2022-11-16 4:45 pm Purchase | 13G | Satsuma Pharmaceuticals Inc. STSA | BML Investment Partners L.P. | 6,440,000 19.400% | 6,440,000 (New Position) | View |
| 2022-11-16 4:10 pm Sale | 13G | Satsuma Pharmaceuticals Inc. STSA | COMMODORE CAPITAL LP | 0 0.000% | -3,711,286 (Position Closed) | View |
| 2022-02-25 5:02 pm Purchase | 13G | Satsuma Pharmaceuticals Inc. STSA | SAMLYN CAPITAL LLC | 2,570,292 8.200% | 800,438 (+45.23%) | View |
| 2022-02-14 4:10 pm Purchase | 13G | Satsuma Pharmaceuticals Inc. STSA | COMMODORE CAPITAL LP | 3,711,286 11.800% | 502,525 (+15.66%) | View |
| 2022-02-14 2:11 pm Purchase | 13G | Satsuma Pharmaceuticals Inc. STSA | SAMLYN CAPITAL LLC | 1,769,854 5.600% | 1,769,854 (New Position) | View |
| 2022-02-11 4:13 pm Purchase | 13G | Satsuma Pharmaceuticals Inc. STSA | TPG GP A LLC | 1,885,939 6.000% | 1,885,939 (New Position) | View |
| 2021-10-19 5:20 pm Purchase | 13G | Satsuma Pharmaceuticals Inc. STSA | COMMODORE CAPITAL LP | 3,208,761 10.200% | 1,089,516 (+51.41%) | View |
| 2021-04-09 4:50 pm Sale | 13G | Satsuma Pharmaceuticals Inc. STSA | MORGAN STANLEY MS | 577,022 1.800% | -416,601 (-41.93%) | View |
| 2021-03-31 08:52 am Purchase | 13D | Satsuma Pharmaceuticals Inc. STSA | Shin Nippon Biomedical Laboratories Ltd. | 2,794,113 8.900% | 2,794,113 (New Position) | View |
| 2021-03-15 2:52 pm Purchase | 13D | Satsuma Pharmaceuticals Inc. STSA | Growth Equity Opportunities 17 LLC | 2,992,958 9.500% | 2,992,958 (New Position) | View |